Quorex and IDEC Pharmaceuticals Ink Collaboration

Sep 03, 2003

NEW YORK, Sept. 3 (GenomeWeb News) - Quorex Pharmaceuticals of Carlsbad, Calif., and IDEC Pharmaceuticals of San Diego today announced a research collaboration seeking novel genes encoding proteins for use as therapeutic targets for cancers and inflammatory disorders.

Quorex will apply its Protein Vision bioinformatics tools -- which include genome annotation, homology modeling, and protein-fold prediction tools -- and receive undisclosed up-front and research payments.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Years and Years

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Diving Evolution

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

This Week in Science

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

Issues to Overcome

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.

Main menu